Safety and Efficacy of Oral Febuxostat in Subjects With Gout

PHASE3CompletedINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Gout

Interventions

DRUG

Febuxostat

DRUG

Allopurinol

All Listed Sponsors

collaborator

Qingdao Shengbang Pharmaceutical Co., Ltd.

INDUSTRY

lead

Xijing Hospital

OTHER

NCT02082769 - Safety and Efficacy of Oral Febuxostat in Subjects With Gout | Biotech Hunter | Biotech Hunter